The Effect of a Novel Hybrid Drug on the Inositol Signaling System in the Yeast Saccharomyces Cerevisiae
Department
Chemistry and Biochemistry
Abstract
Bipolar Disorder is one of the major mental illnesses in the world. While there is insufficient understanding of the mechanism of the disease, many of the drugs used for treatment appear to work via the inositol signaling system. The purpose of this study is to develop a novel hybrid drug-containing valproate and caffeine and determine its impact on the inositol cell signaling system. To do so, the yeast Saccharomyces cerevisiae was grown in varying concentrations of the hybrid drug, and inositol concentration will be measured in cell extracts.
Session
Department of Chemistry & Biochemistry
Event Website
https://www.andrews.edu/services/research/research_events/conferences/urs_honors_poster_symposium/index.html
Start Date
3-26-2021 2:20 PM
End Date
3-26-2021 2:40 PM
The Effect of a Novel Hybrid Drug on the Inositol Signaling System in the Yeast Saccharomyces Cerevisiae
Bipolar Disorder is one of the major mental illnesses in the world. While there is insufficient understanding of the mechanism of the disease, many of the drugs used for treatment appear to work via the inositol signaling system. The purpose of this study is to develop a novel hybrid drug-containing valproate and caffeine and determine its impact on the inositol cell signaling system. To do so, the yeast Saccharomyces cerevisiae was grown in varying concentrations of the hybrid drug, and inositol concentration will be measured in cell extracts.
https://digitalcommons.andrews.edu/honors-undergraduate-poster-symposium/2021/symposium/13
Acknowledgments
Advisors: Desmond Murray & Marlene Murray